Santen Pharmaceutical
Manufacturing · Japan · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Grand Front Osaka Tower A 4-20 Ofuka-cho...Phone Number
+81 676648621Website
www.santen.comRevenue
$2.1 BillionStock Symbol
4536Industry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
5
1
1
1
1
About Santen Pharmaceutical
Santen Pharmaceutical Co., Ltd., is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries. The company was founded in 1890 by Kenkichi Taguchi, as Taguchi Santendo, and in 1925, Santendo Co., Ltd. was established.Explore more
Santen Pharmaceutical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Santen Pharmaceutical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Santen Pharmaceutical has new funding data
Congratulate Masked Content for being promoted to Masked Content at Santen Pharmaceutical
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Santen Pharmaceutical, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Santen Pharmaceutical is spiking on competitors!
Earning: See what the market has to say on Santen Pharmaceutical recently announced quarterly report
Product Launch: Get notified when Santen Pharmaceutical launches new products
Website visits: Recent activity has been detected on your website
Click to see if Santen Pharmaceutical had a recent Job posting/layoffs
Check if Santen Pharmaceutical has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Santen Pharmaceutical as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Santen Pharmaceutical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Santen Pharmaceutical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Santen Pharmaceutical.
Santen Pharmaceutical Tech Stack
A closer look at the technologies used by Santen Pharmaceutical
Most Recent Scoops
Hiring Plans
Santen Pharmaceutical has more open roles in Engineering & Technical than it has had at any time in the past 12 months. Technologies mentioned include: Veeva Systems.
Hiring Plans
Hiring Plans
Santen Pharmaceutical has more open roles in Medical & Health than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Santen Pharmaceutical has more open roles in Information Technology than it has had at any time in the past 9 months.
Hiring Plans
Hiring Plans
Santen Pharmaceutical has more open roles in Finance than it has had at any time in the past 9 months.
Hiring Plans
Open Position
Santen Pharmaceutical News & Media
Santen Receives UK Approval for Ryjunea® (low-dose atropine 0.1 mg/ml) to Slow Progression of Childhood Myopia
First MHRA-approved low-dose atropine eye drop to slow the progression of myopia (short-sightedness) in children aged 3-14 years with a progression rate of 0.5 D or more per year and a severity of -0.5 D to -6.0 D Rates of childhood myopia in the UK have more than doubled over the past 50...RemeGen and Santen Enter into Exclusive Licensing Agreement for Ophthalmic Innovative Drug RC28-E in Greater China and Asian countries
YANTAI, China, Aug. 18, 2025 /PRNewswire/ -- RemeGen Co., Ltd. (Stock Code: 688331.SH/09995.HK, "RemeGen"), a leading Chinese biopharmaceutical company, announced today that it has entered into an agreement with Santen Pharmaceutical (China) Co., Ltd. ("Santen China"), a wholly-owned...Santen Agrees to Licensing Agreements and Asset Transfer for its Pharmaceutical Products in North America
OSAKA, Japan--(BUSINESS WIRE)--Santen Pharmaceutical Co., Ltd. (hereafter Santen) announced today that it has signed licensing agreements and an asset transfer agreement with two U.S. companies. Santen has come to an out-licensing agreement with Visiox Pharmaceuticals, Inc. (hereafter Visiox) on the rights to product manufacturing, commercialization, and sales of OMLONTI®, an eye drop for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension. UndeSanten Announces Health Canada Approval for Cationorm® Plus to Relieve the Symptoms of Dry Eye and Ocular Allergy
TORONTO--(BUSINESS WIRE)--Santen Canada Inc., a subsidiary of Santen Pharmaceutical Co., Ltd. (Santen), today announced the approval of Cationorm® Plus by Health Canada. Cationorm® Plus is a unique hydrating artificial tear that restores moisture in the eye to provide long-lasting relief for dry eye and ocular allergy symptoms. Dry eye occurs when there is a problem with the tear film that normally keeps the eyes moist and lubricated.1,2,3 Symptoms of dry eye include redness, burning, stinging,
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Santen Pharmaceutical
Sign Up For FreeTo access detailed company insights
Santen Pharmaceutical Co., Ltd., is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries. The company was founded in 1890 by Kenkichi Taguchi, as... Read More
